Toxicogenomics and clinical toxicology: An example of the connection between basic and applied sciences

Toxicology Letters

Volumn 186, Issue 1, 2009, Pages 2-8

  Ferrer Dufol, Ana ^a   Menao Guillen, Sebastian ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

Clinical toxicology; Toxicogenomics; Toxicokinetic and toxicodynamic

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ALCOHOL; ALCOHOL DEHYDROGENASE; ALDEHYDE DEHYDROGENASE; AMPHETAMINE DERIVATIVE; CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; GLUTATHIONE; N ACETYL 1,4 BENZOQUINONE IMINE; OPIATE DERIVATIVE; PARACETAMOL;

ALCOHOL INTOXICATION; ALCOHOL METABOLISM; ARTICLE; DNA POLYMORPHISM; DOPAMINERGIC SYSTEM; EVOLUTIONARY ADAPTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOMICS; HIGH RISK POPULATION; HUMAN; LIVER TOXICITY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; PROTEOMICS; RACE DIFFERENCE; TOXICOGENETICS; TOXICOKINETICS; TRANSGENIC MOUSE;

ANIMALS; BIOMEDICAL RESEARCH; CLINICAL MEDICINE; GENETIC VARIATION; HUMANS; PREDICTIVE VALUE OF TESTS; SPECIES SPECIFICITY; TOXICOGENETICS; XENOBIOTICS;

EID: 61349196838     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2008.10.025     Document Type: Article

References (60)

1. Adinolfi A., and Hopkinson D.A. Affinity electrophoresis of human alcohol dehydrogenase (ADH) isozymes. Ann. Hum. Genet. 43 (1979) 109-119
2. Agrawal A., Pergadia M.L., Saccone S.F., Hinrichs A.L., Lessov-Schlaggar C.N., Saccone N.L., Neuman R.J., Breslau N., Johnson E., Hatsukami D., Montgomery G.W., Heath A.C., Martin N.G., Goate A.M., Rice J.P., Bierut L.J., and Madden P.A. Gamma-aminobutyric acid receptor genes and nicotine dependence: evidence for association from a case-control study. Addiction 103 (2008) 1027-1038
3. Bond C., LaForge K.S., Tian M., Melia D., Zhang S., Borg L., Gong J., Schluger J., Strong J.A., Leal S.M., Tischfield J.A., Kreek M.J., and Yu L. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc. Natl. Acad. Sci. 95 (1998) 9608-9613
4. Bonnichsen R.K., and Wassen A.M. Crystalline alcohol dehydrogenase from horse liver. Arch. Biochem. Biophys. 18 (1948) 361-363
5. Bosron W.F., Li T.K., and Vallee B.L. New molecular forms of human liver alcohol dehydrogenase: isolation and characterization of ADH (Indianapolis). Proc. Natl. Acad. Sci. 77 (1980) 5784-5788
6. Buckle V.J., Fujita N., Bateson A.N., Darlison M.G., and Barnard E.A. Localization of human GABA-A receptor subunit genes to chromosomes 4 and 5. Cytogenet. Cell Genet. 51 (1989) 972-1972
7. Burnichon V., Jean S., Bellon L., Maraninchi M., Bideau C., Orsière T., Margotat A., Gérolami V., Botta A., and Bergé-Lefranc J.L. Patterns of gene expressions induced by arsenic trioxide in cultured human fibroblasts. Toxicol. Lett. 143 (2003) 155-162
8. Cheung C., Yu A.M., Ward J.M., Krausz K.W., Akiyama T.E., Feigenbaum L., and Gonzalez F.J. The cyp2e1-humanized transgenic mouse: role of cyp2e1 in acetaminophen hepatotoxicity. Drug. Metab. Dispos. 33 (2005) 449-457
9. Cossette P., Liu L., Brisebois K., Dong H., Lortie A., Vanasse M., Saint-Hilaire J.M., Carmant L., Verner A., Lu W.Y., Wang Y.T., and Rouleau G.A. Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy. Nat. Genet. 31 2 (2002) 184-189
10. Crabb D.W., Edenberg H.J., Bosron W.F., and Li T.K. Genotypes for aldehyde dehydrogenase deficiency and alcohol sensitivity: the inactive ALDH2*2 allele is dominant. J. Clin. Invest. 83 (1989) 314-316
11. Eckey R., Agarwal D.P., Saha N., and Goedde H.W. Detection and partial characterization of a variant form of cytosolic aldehyde dehydrogenase isozyme. Hum. Genet. 72 (1986) 95-97
12. Elbashir S.M., Harborth J., Weber K., and Tuschl T. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26 (2002) 199-213
13. Fenna D., Mix L., Schaefer O., and Gilbert J.A.L. Ethanol metabolism in various racial groups. Can. Med. Assoc. J. 105 (1971) 472-475
14. Ferguson S.M., Fasano S., Yang P., Brambilla R., and Robinson T.E. Knockout of ERK1 enhances cocaine-evoked immediate early gene expression and behavioral plasticity. Neuropsychopharmacology 31 (2006) 2660-2668
15. Fox M.A., Andrews A.M., Wendland J.R., Lesch K.P., Holmes A., and Murphy D.L. A pharmacological analysis of mice with a targeted disruption of the serotonin transporter. Psychopharmacology 195 (2007) 147-166
16. Gfeller E., Kuhart M.J., and Snyder S.H. Neurotransmitter-specific synaptosomes in rat corpus striatum: morphological variations. Proc. Natl. Acad. Sci. 68 (1971) 155-159
17. Goedde H.W., Harada S., and Agarwal D.P. Racial differences in alcohol sensitivity: a new hypothesis. Hum. Genet. 51 (1979) 331-334
18. Greenfield N.J., and Pietruszko R. Two aldehyde dehydrogenases from human liver: isolation via affinity chromatography and characterization of the isozymes. Biochim. Biophys. Acta 483 (1977) 35-45
19. Guo W.J., Lanzi G., Luobu O., Ma X.H., Wang Y.C., Pu Z., Wei G., Ji Y.L., Wang Z., Yan C.Y., Zhuma B., Shi X.M., Liu X.H., Collier D.A., Ball D., and Li T. Functional polymorphism of CYP2E1 gene and alcohol use disorders in a Tibetan population. Zhong. Nan. Da. Xue. Xue. Bao. Yi. Xue. Ban. 33 (2008) 284-292
20. Hamilton R.J. Withdrawal Principles. Goldfranks Toxicological Emergencies. 8th ed. (2006), McGraw Hill
21. Harada S., Misawa S., Agarwal D.P., and Goedde H.W. Liver alcohol dehydrogenase and aldehyde dehydrogenase in the Japanese: isozyme variation and its possible role in alcohol intoxication. Am. J. Hum. Genet. 32 (1980) 8-15
22. Harries H.M., Fletcher S.T., Duggan C.M., and Baker V.A. The use of genomics technology to investigate gene expression changes in cultured human liver cells. Toxicol. In Vitro 15 (2000) 399-405
23. Haughey H.M., Ray L.A., Finan P., Villanueva R., Niculescu M., and Hutchison K.E. Human gamma-aminobutyric acid A receptor alpha2 gene moderates the acute effects of alcohol and brain mRNA expression. Genes Brain Behav. 7 (2008) 447-454
24. Hayashi S., Watanabe J., and Kawajiri K. Genetic polymorphisms in the 5-prime-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J. Biochem. 110 (1991) 559-565
25. Hsu L.C., Tani K., Fujiyoshi T., Kurachi K., and Yoshida A. Cloning of cDNAs for human aldehyde dehydrogenases 1 and 2. Proc. Natl. Acad. Sci. 82 (1985) 3771-3775
26. Hu Y., Ingelman-Sundberg M., and Lindros K.O. Induction mechanisms of cytochrome P450 2E1 in liver: interplay between ethanol treatment and starvation. Biochem. Pharmacol. 50 (1995) 155-161
27. Hwang G.W., Hayashi T., Kita K., Takahashi T., Kuge S., and Naganuma A. siRNA-mediated inhibition of phosphatidylinositol glycan Class B (PIGB) confers resistance to methylmercury in HEK293 cells. J. Toxicol. Sci. 32 (2007) 581-583
28. Impraim C., Wang G., and Yoshida A. Structural mutation in a major human aldehyde dehydrogenase gene results in loss of enzyme activity. Am. J. Hum. Genet. 34 (1982) 837-841
29. Jeong S.Y., Lim J.S., Park H.J., Cho J.W., Rana S.V., and Yoon S. Effects of acetaminophen on hepatic gene expression in mice. Physiol. Chem. Phys. Med. NMR 38 (2006) 77-83
30. Koop D.R., Morgan E.T., Tarr G.E., and Coon M.J. Purification and characterization of a unique isozyme of cytochrome P-450 from liver microsomes of ethanol-treated rabbits. J. Biol. Chem. 257 (1982) 8472-8480
31. Koop D.R., and Tierney D.J. Multiple mechanisms in the regulation of ethanol-inducible cytochrome P450IIE1. Bioessays 12 (1990) 429-435
32. Lakshman R., Cederbaum A.I., Hoek J.B., Kinishi M., Koop D., and Donohu T.M. Use of CYP2E1-tranfected human liver cell lines in elucidating the actions of ethanol. Alcohol Clin. Exp. Res. 29 (2005) 1726-1734
33. Lieber C.S., and deCarli L.M. Hepatic microsomal etanol oxidizing system. In vitro characteristics and adaptative properties in vivo. J. Biol. Chem. 245 (1970) 2505-2512
34. Lieber C.S., and deCarli L.M. The role of hepatic microsomal ethanol oxidizing system (MEOS) for ethanol metabolism in vivo. J. Pharmacol. Exp. Ther. 181 (1972) 279-287
35. Liu Y., Yoshimura K., Hanaoka T., Ohnami S., Ohnami S., Kohno T., Yoshida T., Sakamoto H., Sobue T., and Tsugane S. Association of habitual smoking and drinking with single nucleotide polymorphism (SNP) in 40 candidate genes: data from random population-based Japanese samples. J. Hum. Genet. 50 (2005) 62-68
36. McGehee, Ronis M.J., Cowherd R.M., Ingelman-Sundberg M., and Badger T.M. Characterizatiom of cytochrome P450 2E1 induction in a rat hepatoma FGC-4 cell model by ethanol. Biochem. Pharmacol. 48 (1994) 1823-1833
37. Nakajima T., Yonekura I., and Sato A. A simple method to evaluate liver microsomal enzyme activity for phenol with a high performance liquid chromatograph. Toxicol. Lett. 29 (1985) 11-15
38. Novak R.F., and Woodcroft K.J. The alcohol-inducible form of cytochrome P450 (CYP 2E1): role in toxicology and regulation of expression. Arch. Pharm Res. 23 (2000) 267-282
39. Okamoto K., Murawaki Y., Yuasa I., and Kawasaki H. Effect of ALDH2 and CYP2E1 gene polymorphisms on drinking behavior and alcoholic liver disease in Japanese male workers. Alcohol Clin. Exp. Res. 25 6Suppl (2001) 19S-23S
40. Osier M.V., Pakstis A.J., Soodyall H., Comas D., Goldman D., Odunsi A., Okonofua F., Parnas J., Schulz L.O., Bertranpetit J., Bonne-Tamir B., Lu R.B., Kidd J.R., and Kidd K.K. A global perspective on genetic variation at the ADH genes reveals unusual patterns of linkage disequilibrium and diversity. Am. J. Hum. Genet. 71 (2002) 84-99
41. Pasanen M., Haaparanta T., Sundin M., Sivonen P., Vakakangas K., Raunio H., Hines R., Gustafsson J.A., and Pelkonen O. Immunochemical and molecular biological studies on human placental cigarette smoke-inducible cytochrome P-450-dependent monooxygenase activities. Toxicology 62 (1990) 175-187
42. Pineau T., Costet P., Puel O., Pfohl-Leszkowicz A., Lesca P., Alvinerie M., and Galtier P. Knockout animals in toxicology: assessment of toxin bioactivation pathways using mice deficient in xenobiotic metabolizing enzymes. Toxicol. Lett. 102-103 (1998) 459-464
43. Rahman Z., Schwarz J., Gold S.J., Zachariou V., Wein M.N., Choi K.H., Kovoor A., Chen C.K., DiLeone R.J., Schwarz S.C., Selley D.E., Sim-Selley L.J., Barrot M., Luedtke R.R., Self D., Neve R.L., Lester H.A., Simon M.I., and Nestler E.J. RGS9 modulates dopamine signaling in the basal ganglia. Neuron 38 (2003) 941-952
44. Roberts B.J., Song B., Soh Y., Park S.S., and Shoaf S.E. Ethanol induces CYP2E1 by protein stabilization. J. Biol. Chem. 270 (1995) 29632-29635
45. Ronis M.J., Huang J., Crouch J., Mercado C., Irby D., Valentine C.R., Lumpkin C.K., Ingelman-Sundberg M., and Badger T.M. Cytochrome P450 CYP2E1 induction during chronic alcohol exposure occurs by a two step-mechanism associated with blood alcohol concentrations in rats. J. Pharmacol. Exp. Ther. 264 (1993) 944-950
46. Ruepp S.U., Tonge R.P., Shaw J., Wallis N., and Pognan F. Genomics and proteomics analysis of acetaminophen toxicity in mouse liver. Toxicol. Sci. 65 (2002) 135-150
47. Smith M., Hopkinson D.A., and Harris H. Developmental changes and polymorphism in human alcohol dehydrogenase. Ann. Hum. Genet. 34 (1971) 251-272
48. Stamatoyannopoulos G., Chen S.H., and Fukui M. Liver alcohol dehydrogenase in Japanese: high population frequency of atypical form and its possible role in alcohol sensitivity. Am. J. Hum. Genet. 27 (1975) 789-796
49. Sun F., Tsuritani I., Honda R., Ma Z.Y., and Yamada Y. Association of genetic polymorphisms of alcohol-metabolizing enzymes with excessive alcohol consumption in Japanese men. Hum. Genet. 105 (1999) 295-300
50. Tanaka F., Shiratori Y., Yokosuka O., Imazeki F., Tsukada Y., and Omata M. Polymorphism of alcohol-metabolizing genes affects drinking behavior and alcoholic liver disease in Japanese men. Alcohol. Clin. Exp. Res. 21 (1997) 596-601
51. Thomasson H.R., Edenberg H.J., Crabb D.W., Mai X.L., Jerome R.E., Li T.K., Wang S.P., Lin Y.T., Lu R.B., and Yin S.J. Alcohol and aldehyde dehydrogenase genotypes and alcoholism in Chinese men. Am. J. Hum. Genet. 48 (1991) 677-681
52. Tsutsumi M., Lasker J.M., Takahashi T., and Lieber C.S. In vivo induction of hepatic P4502E1 by ethanol: role of increased enzyme synthesis. Arch. Biochem. Biophys. 304 (1993) 209-218
53. Ueshima Y., Tsutsumi M., Takase S., Matsuda Y., and Kawahara H. Acetaminophen metabolism in patients with different cytochrome P-4502E1 genotypes. Alcohol Clin. Exp. Res. 20 1 Suppl (1996) 25A-28A
54. Volkow N.D., Wang G.J., Fowler J.S., Logan J., Gatley S.J., Wong C., Hitzemann R., and Pappas N.R. Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors. J. Pharmacol. Exp. Ther. 291 1 (1999) 409-415
55. Wolff P.H. Ethnic differences in alcohol sensitivity. Science 175 (1972) 449-450
56. Wolf K.K., Wood S.G., Allard J.L., Hunt J.A., Gorman N., Walton-Strong B.W., Szakacs J.G., Duan S.X., Hao Q., Court M.H., von Moltke L.L., Greenblatt D.J., Kostrubsky V., Jeffery E.H., Wrighton S.A., Gonzalez F.J., Sinclair P.R., and Sinclair J.F. Role of CYP3A and CYP2E1 in alcohol-mediated increases in acetaminophen hepatotoxicity: comparison of wild-type and Cyp2e1(-/-) mice. Drug Metab. Dispos. 35 7 (2007) 1223-1231
57. Xu M., Moratalla R., Gold L.H., Hiroi N., Koob G.F., Graybiel A.M., and Tonegawa S. Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell 79 (1994) 729-742
58. Yoshida A., Huang I.Y., and Ikawa M. Proc. Natl. Acad. Sci. U.S.A. 81 (1984) 258-261
59. Yoshida A., Dave V., Ward R.J., and Peters T.J. Cytosolic aldehyde dehydrogenase (ALDH1) variants found in alcohol flushers. Ann. Hum. Genet. 53 (1989) 1-7
60. Zhang S., Xu N., Nie J., Dong L., Li J., and Tong J. Proteomic alteration in lung tissue of rats exposed to cigarette smoke. Toxicol. Lett. 178 3 (2008) 191-196